Challenges associated with mutational screening of suspected myeloproliferative neoplasms in a regional diagnostic laboratory

被引：0
|
作者：
Cullen, F. L. [1 ]
Evans, P. [1 ]
Crouch, S. [2 ]
Lightfoot, T. [2 ]
Kelly, R. J. [1 ]
Cargo, C. [1 ]
机构：
[1] St James Univ Hosp, Haematol Malignancy Diagnost Serv, Leeds LS9 7TF, W Yorkshire, England
[2] Univ York, Epidemiol & Canc Study Grp, York YO10 5DD, N Yorkshire, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2016年 / 173卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
335
引用
收藏
页码：136 / 137
页数：2
相关论文
共 27 条
  • [21] Response to the letter by Langabeer on "Retrospective screening for Philadelphia-negative myeloproliferative neoplasms in patients with cerebral infarctions as revealed using the revised 2016 World Health Organization diagnostic criteria"
    Song, Ik-Chan
    BLOOD RESEARCH, 2020, 55 (01) : 68 - 68
  • [22] Diagnostic challenges associated with adrenocortical neoplasms arising from adreno-hepatic fusion: a case report of two patients and a literature review
    Lee, Ja Kyung
    Kong, Yoon
    Lee, Ji Ae
    Kong, Sung Hye
    Na, Hee Young
    Yu, Hyeong Won
    Choi, June Young
    Lee, Hae Won
    Park, So Yeon
    GLAND SURGERY, 2024, 13 (12) : 2420 - 2429
  • [23] FISH AND MUTATIONAL SCREENING OF THE ABL, SYK AND JAK TYROSINE KINASE FAMILY GENES IN BCR-ABL1 NEGATIVE AND JAK2V617F NEGATIVE CHRONIC MYELOPROLIFERATIVE NEOPLASMS (CMPNS)
    Ormazabal, C.
    Aranaz, P.
    Hurtado, C.
    Erquiaga, I.
    Calasanz, M. J.
    Garcia-Delgado, M.
    Novo, F. J.
    Vizmanos, J. L.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 581 - 582
  • [24] Clinicopathological differences exist between CALR- and JAK2-mutated myeloproliferative neoplasms despite a similar molecular landscape: data from targeted next-generation sequencing in the diagnostic laboratory
    Agarwal, Rishu
    Blombery, Piers
    McBean, Michelle
    Jones, Kate
    Fellowes, Andrew
    Doig, Ken
    Forsyth, Cecily
    Westerman, David A.
    ANNALS OF HEMATOLOGY, 2017, 96 (05) : 725 - 732
  • [25] Clinicopathological differences exist between CALR- and JAK2-mutated myeloproliferative neoplasms despite a similar molecular landscape: data from targeted next-generation sequencing in the diagnostic laboratory
    Rishu Agarwal
    Piers Blombery
    Michelle McBean
    Kate Jones
    Andrew Fellowes
    Ken Doig
    Cecily Forsyth
    David A. Westerman
    Annals of Hematology, 2017, 96 : 725 - 732
  • [26] Screening for fusion genes involving PDGFRA or PDGFRB in patients with eosinophilia associated myeloproliferative neoplasms (Eos-MPN) using the Fluidigm BioMark real-time PCR system and 48 48 Dynamic Array
    White, Helen
    Scott, D. J.
    Huggett, J.
    Hall, V. J.
    Waghorn, K.
    Lyons, M.
    Sanders, R.
    Foy, C. A.
    Cross, N. C. P. C.
    JOURNAL OF MEDICAL GENETICS, 2010, 47 : S69 - S69
  • [27] Institutional Review of Rapid Next Generation Sequencing Panel for Myeloproliferative Neoplasms Reveals Unreported Diagnostic Patient Genomic Information in Other Hematologic Malignancies. Justification for Ordering Larger Screening Panels and Reviewing Unreported Results in the Interest of Patient Safety
    Tizro, Parastou
    Vail, Eric
    Zhang, Wenjuan
    Gayhart, Matthew
    Eno, Celeste
    LABORATORY INVESTIGATION, 2024, 104 (03) : S2037 - S2038
123